Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm
Risk & Insurance - May 12, 2025
GLP-1 agonist drugs are designed to treat type 2 diabetes, but their secondary weight loss effect is driving popularity. The post Understanding GLP-1 Agonists: The ‘Weight Loss’ Drugs Taking the World by Storm appeared first on Risk & Insurance. ...
Recommended Articles
Posted: May 13, 2025
If the judiciary is willing to ignore the law as a means of correcting perceived injustice, sooner o...
Posted: May 12, 2025
Trade dynamics are complex and interconnected. The post RISKWORLD™ 2025 Coverage: Sompo’s Jame...
Posted: May 12, 2025
AI-driven innovation and strategic investments fuel the 'insurtech spring' as P&C insurtechs le...